Sylvie Gregoire

Dr. Sylvie Louise Grégoire, PharmD is a Massachusetts biotechnology and pharmaceutical company executive. She is currently the President of the Human Genetics division at Shire plc. Gregoire has a doctorate in Pharmacy and Pharmacology. Sylvie Gregoire is also a dual US and Canadian citizen, lives in Boston, Massachusetts and is active in philanthropy in the Boston area.

Prior to being the President of one of Shire plc's two divisions she was the chairwoman of the board of drug company IDM Pharma; she was also a board member of Cubist Pharmaceuticals (CBST) and Caprion Proteomics. In addition, Gregoire was also President and Chief Executive Officer of Glycofi Inc. (now a wholly owned subsidiary of Merck & Co.) and the Executive Vice President of Biogen Idec.

Education

*Université Laval ("Laval University"), Quebec City, Canada: Faculty of Pharmacy
*University of Buffalo: Doctorate of Pharmacy

Community involvement

*Member of the board of trustees of the International School of Boston
*Member of the board of the Greater Boston Food Bank
*Active in the Accelerated Cure Project (a charity committed to curing Multiple Sclerosis)

External links and references

* [http://www.shire.com/shire/InvestorRelations/regulatorynews_item.jsp?ric=SHP.L&ref=18568 Shire plc press release announcing Sylvie Gregoire as President of the Human Genetics division
* [http://www.cubist.com/about/bod.php Cubist Pharmaceuticals website page describing Sylvie Grégoire and the company's board of directors]